Literature DB >> 30397278

Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Sanjiv B Amin1, Tristram Smith2, Geralyn Timler3.   

Abstract

Bilirubin-induced brain injury in the neonatal period has detrimental effects on neurodevelopment that persist into childhood and adulthood, contributing to childhood developmental disorders. Unconjugated bilirubin is a potent antioxidant that may be useful for protecting against oxidative injuries, but it becomes a potent neurotoxin once it crosses the blood brain barrier. Because bilirubin toxicity involves a myriad of pathological mechanisms, can damage most types of brain cells, and affects brain circuits or loops that influence cognition, learning, behavior, sensory, and language, the clinical effects of bilirubin-induced neurotoxicity are likely to be manifold. One possible effect that several experts have identified is bilirubin-induced neurological dysfunction (subtle kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus could lead to developmental disorders has not been elucidated previously. Our aim in this review is to describe a spectrum of developmental disorders that may reflect subtle kernicterus and outline plausible biological mechanisms for this possible association. We review existing evidence that support or refute the association between unconjugated hyperbilirubinemia and developmental disorders, and limitations associated with these studies.

Entities:  

Mesh:

Year:  2018        PMID: 30397278     DOI: 10.1038/s41390-018-0216-4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  120 in total

Review 1.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

Review 2.  Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights.

Authors:  Dora Brites
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

Review 3.  Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes.

Authors:  Courtney J Wusthoff; Irene M Loe
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-10       Impact factor: 3.926

4.  CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients.

Authors:  C B Hyman; J Keaster; V Hanson; I Harris; R Sedgwick; H Wursten; A R Wright
Journal:  Am J Dis Child       Date:  1969-04

Review 5.  The clinical syndrome of bilirubin-induced neurologic dysfunction.

Authors:  Lois Johnson; Vinod K Bhutani
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

6.  The neuropathology of kernicterus in the premature neonate: diagnostic problems.

Authors:  M Ahdab-Barmada; J Moossy
Journal:  J Neuropathol Exp Neurol       Date:  1984-01       Impact factor: 3.685

Review 7.  Hyperbilirubinemia: subcortical mechanisms of cognitive and behavioral dysfunction.

Authors:  Leonard F Koziol; Deborah Ely Budding; Dana Chidekel
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

Review 8.  Bilirubin-induced neural impairment: a special focus on myelination, age-related windows of susceptibility and associated co-morbidities.

Authors:  Dora Brites; Adelaide Fernandes
Journal:  Semin Fetal Neonatal Med       Date:  2014-12-19       Impact factor: 3.926

Review 9.  Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).

Authors:  Steven M Shapiro
Journal:  J Perinatol       Date:  2005-01       Impact factor: 2.521

10.  Cytotoxicity is predicted by unbound and not total bilirubin concentration.

Authors:  Sebastián D Calligaris; Cristina Bellarosa; Pablo Giraudi; Richard P Wennberg; J Donald Ostrow; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2007-11       Impact factor: 3.756

View more
  6 in total

Review 1.  Neonatal Jaundice and Autism: Precautionary Principle Invocation Overdue.

Authors:  Vera K Wilde
Journal:  Cureus       Date:  2022-02-23

2.  Molecular Genetic Screening of Neonatal Intensive Care Units: Hyperbilirubinemia as an Example.

Authors:  Yuqi Yang; Yu Wang; Lingna Zhou; Wei Long; Bin Yu; Huaiyan Wang
Journal:  Appl Clin Genet       Date:  2022-05-18

3.  Vascular network expansion, integrity of blood-brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat.

Authors:  Sandrine Blondel; Nathalie Strazielle; Amel Amara; Rainui Guy; Christine Bain; Alix Rose; Laurent Guibaud; Claudio Tiribelli; Silvia Gazzin; Jean-François Ghersi-Egea
Journal:  Fluids Barriers CNS       Date:  2022-06-07

Review 4.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

5.  Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.

Authors:  Shoko Miura; Keiko Tsuchie; Michiyo Fukushima; Ryosuke Arauchi; Toshiko Tsumori; Koji Otsuki; Maiko Hayashida; Sadayuki Hashioka; Rei Wake; Tsuyoshi Miyaoka; Masatoshi Inagaki; Arata Oh-Nishi
Journal:  Pediatr Res       Date:  2021-03-31       Impact factor: 3.756

6.  Risk of autism spectrum disorder in children with a history of hospitalization for neonatal jaundice.

Authors:  Gaffari Tunç; Ayla Uzun Çiçek; Fatih Kiliçbay
Journal:  Turk J Med Sci       Date:  2021-08-04       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.